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Lipophilicity of Opioids Determined by a Novel Micromethod 
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The lipophilicity of various k-selective opioids was determined by measuring their distribu- 
tion between n-octanol and Tris.HCl buffer, pH 7.4, by a procedure requiring submicromo- 
lar concentrations (submilligram amounts) of the compounds. After partitioning at 2X, 
the concentration of opioids in the aqueous phase was quantified by their displacement of 
bound [3H]Tyr-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) from opioid receptor in brain mem- 
branes. The obtained distribution coefficients (log P,,,) agreed well with respective values 
determined previously with other, less sensitive or more cumbersome, methods of quantita- 
tion. The procedure is precise and versatile, and offers the routine assessment of lipophilic- 
ity as part of the in vitro characterization of opioids frequently available in limited quan- 
tities. In principle, the method is applicable to any compound whose binding to its receptor 
is quantifiable. 
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INTRODUCTION 
In numerous studies, the lipophilicity of opioids has 
been related to the effectiveness of their pharmacologic 
action. For example, lipophilic opioids were equipo- 
tent when given either systemically or intrathecally, 
whereas hydrophilic opioids had a much higher po- 
tency following intrathecal administration (Herz and 
Teschemacher, 1971). Furthermore, the influence of 
lipophilicity on the time course of pharmacologic ac- 
tion and on the receptor kinetics of opioids has been 
described (Hambrook and Rance, 1976). The lipophil- 
icity of opioids has previously been determined by their 
distribution between aqueous medium and organic sol- 
vents using different methods of quantitation, includ- 
ing spectrophotometry (Herz and Teschemacher, 
1971), electrometric titration (Kaufman et al., 1975), 
and the measurement of radioactivity (Misra et al., 
1974). A drawback of these procedures is either the 
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lack of sensitivity or the required availability of the 
tested opioids in radiolabeled form. On the other hand, 
we have established a procedure in this study that pro- 
vides distribution coefficients for opioids present at 
submilligram amounts, offering thereby routine appli- 
cability and a high degree of accuracy and precision. 
METHODS 
[ 3H]Tyr-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) and 
[3H]etorphine were purchased from Amersham Corpo- 
ration, and the unlabeled opioids were obtained 
through the Narcotic Drug and Opiate Peptide Basic 
Research Center at the University of Michigan Medical 
School. Isolation of membranes from rat and monkey 
brain were carried out as described (Clark et al., 1988). 
For partitioning, the tested opioid was routinely dis- 
solved at a concentration of 3 p,M each in 50 mM 
TrisaHCl, pH 7.4 that had been saturated at 25°C with 
n-octanol, and in n-octanol preequilibrated with the 
Tris buffer. Alternatively, salt forms of opioids can be 
dissolved in the buffer, and bases in octanol. Equal 
volumes of the aqueous phase and n-octanol were 
shaken at 25°C in a small separatory funnel or a tube for 
60 min at approximately 140 strokes per min (Eberbach 
horizontal shaker). The two phases were allowed to 
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separate for 30 min, the organic layer was aspirated, 
and an aliquot of the lower aqueous layer was collected 
into a glass tube. The tube was centrifuged at 1000 g 
for 10 min at 25°C to complete the phase separation. 
After renewed aspiration of the octanol phase, samples 
of the aqueous layer were removed and subjected to 
the opioid-receptor binding assay. Necessary dilutions 
in the assay were made using octanol-equilibrated 
Tris.HCI buffer, pH 7.4. 
Considering the p_ receptor selectivity of the tested 
opioids, their concentration in the aqueous layer before 
and after partitioning was quantified by displacement 
of 0.5 nM [‘HIDAMGO as described (Clark et al., 
1988). Alternatively, particularly for nonselective 
opioids, the displacement of 0.5 nM [3H]etorphine can 
be used for quantitation. Receptor-specific binding was 
determined with an appropriate excess of the respec- 
tive unlabeled opioid. The inhibition of radioligand 
binding was standardized with five different concentra- 
tions of the tested opioid. The ICo values and slope 
factors were determined by linear regression analysis 
from Hill plots, relating percent inhibition of radioli- 
gand binding to five concentrations of the competing 
opioid. The correlation coefficient (r*) of the linear 
regression was higher than 0.98 in all cases. From the 
obtained ECso plots, the inhibition of radioligand bind- 
ing by the tested opioid was related to its concentration 
in the aqueous phase before and after partitioning, and 
expressed as apparent partition coefficient (log Pa&. 
The latter parameter reflects the partitioning of free 
base and of acid salt between the organic solvent and 
aqueous phase. 
RESULTS 
As shown in Table 1, the procedure described here 
provides partition coefficients with a degree of preci- 
sion comparable to that obtained using automated high- 
performance liquid chromatography (Garst and Wil- 
son, 1984). The major feature of the method is its adapt- 
ability to minute amounts of opioids: the partitioning 
of a 10 mL 1 FM solution of an opioid with a molecular 
weight of 300 requires 3 kg of the compound. Further- 
more, assuming that the tested opioid displaces 
[3H]DAMG0 or [3H]etorphine in the binding assay 
with an I& of 100 nM, <l kg of the compound is 
sufficient to obtain a concentration-binding inhibition 
plot with five different concentrations, each run in du- 
plicate. Actually, the limiting factors of sensitivity in 
applying this procedure are the availability of suitable 
containers for the partitioning of small volumes, and 
the weighing of submilligram amounts of the sample. 
The required sensitivity of the procedure is adjustable 
by the appropriate selection of 1) partition volumes, 2) 
initial concentration of opioids, and 3) dilutions of the 
partitioned aqueous phase subjected to quantitation. 
There was a remarkably good agreement between 
the partition coefficients determined in this study and 
those obtained previously with different methods of 
quantitation (Table 1). The low value for etorphine re- 
ported in one of the referenced studies (Herz and 
Teschemacher, 1971) is puzzling. Considering the 
structural features of the opioids listed in Table 1, the 
values obtained in this work and in the detailed investi- 
gation by Kaufman (1978) seem more appropriate. In 
the latter study, the strong influence of temperature 
TABLE 1 Lipophilicity of Opioids: Octanol-Water Partition Coeffkients Determined by Various Methods of Quantitation 
Determined Reported 
Opioid Log PApp Values Reference 
Sufentanil 3.55 3.24 Leyson et al. (1983) 
(2 0.02) 
Etorphine 2.19 1.86; 2.76 Herz and Teschemacher (1971); Kaufman (1978) 
(Ir 0.02) 
Levallorphan 2.19 2.03 Kaufman et al. ( 1975) 
(k 0.02) 
Methadone 1.82 1.63; 1.74 Kaufman et al. (1975); Misra et al. (1974) 
(2 0.05) 
Naloxone 1.04 1.12; 0.73 Kaufman et al. (1975); Misra et al. (1974) 
(2 0.08) 
Levorphanol 0.96 0.62: 0.94 Kaufman et al. (1975); Misra et al. (1974) 
(? 0.07) 
Morphine -0.21 0.068; 0; -0.12 Herz and Teschemacher (1971); Kaufman 
(k 0.01) (1978); Misra et al. (1974) 
Shown are mean values and ?SEM (in parentheses) of four determinations of log P,,,. The receptor assay was carried out with 
13HlDAMG0 and several concentrations of the partitioned opioid, as described in the Methods section. Also listed are published partition 
coefficients obtained with different methods of quantitation. 
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and pH on the partition coefficient for etorphine was 
emphasized. Unfortunately, the provided information 
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on specified conditions under which some reported 
partition coefficients were obtained is incomplete. 
DISCUSSION 
In addition to the established significance of lipo- 
philicity in the function of opioids, its role in the devel- 
opment of novel opioids has recently been highlighted. 
Based on the number of positive charges and the pres- 
ence of hydrophobic amino acid residues, such as 
naphthylalanine, the lipophilicity of newly synthesized 
opioid peptides was influential in targeting these com- 
pounds to the central nervous system or periphery and 
determining their receptor binding selectivity (Schiller 
et al., 1989). Thus, the multifaceted significance of lipo- 
philicity points to the need to consider it as an impor- 
tant molecular property of opioids. The method for its 
quantitation described here offers a unique combina- 
tion of sensitivity, accuracy, precision, and versatility. 
By selecting the appropriate radiolabeled ligand in the 
binding assay, the procedure becomes applicable to 
opioids of different receptor selectivity. For example, 
the displacement of [3H]etorphine allows the quantita- 
tion of either TV,, 6, or K opioids in the aqueous phase 
following partitioning. Alternatively, if dealing with se- 
lective opioids, radiolabeled DAMGO, DPDPE, or 
U69,593 can be used (Clark et al., 1988). Conveniently, 
the procedure can be carried out in conjunction with 
the determination of receptor binding of the tested opi- 
oid: different aliquots of a common stock solution can 
be used to obtain a measure of binding affinity (KS,,) 
and lipophilicity (log Pap,,). Significantly, the routine 
applicability of the method provides an additional bio- 
chemical determinant in the preclinical evaluation of 
novel opioids frequently available in limited amounts 
(Medzihradsky, 1987). 
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